XML 35 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
Related Party Transactions (Tables)
3 Months Ended
Mar. 31, 2015
Related Party Transactions [Abstract]  
Summary of activities related to related party

Milestones Payments 
    
(1) filing of an New Drug Application (“NDA”) or regulatory approval for each licensed product $750,000 
(2) upon the receipt of regulatory approval from the U.S. FDA for each licensed product  1,750,000